Related Experiment Video
Updated: Jan 17, 2026
05:10
Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
Published on: December 11, 2016
10.2K
Pharmacogenomics: a reality or still a promise?
1H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA. beplerg@moffitt.usf.edu
Lung Cancer (Amsterdam, Netherlands)
|October 27, 2006
Summary
Despite advances, non-small cell lung cancer (NSCLC) has a poor prognosis. A pharmacogenomic approach may improve survival for specific NSCLC patient groups, guiding future treatment strategies.
Area of Science:
- Oncology
- Genetics
- Pharmacology
Background:
- Non-small cell lung cancer (NSCLC) remains a significant health challenge with a generally poor prognosis for most patients, despite recent therapeutic advancements.
- Identifying clinical predictors of outcome is crucial for improving patient survival and tailoring treatment strategies.
- Emerging research highlights the role of specific genetic factors in NSCLC progression and therapeutic response.
Purpose of the Study:
- To explore the potential of a pharmacogenomic approach in improving outcomes for non-small cell lung cancer patients.
- To identify clinical predictors of outcome in NSCLC by leveraging genetic information.
- To inform evolving treatment strategies for NSCLC based on personalized medicine.
Main Methods:
- Review of recent evidence on pharmacogenomic applications in cancer treatment.
- Analysis of genetic factors influencing NSCLC progression and response to therapy.
- Exploration of clinical predictors for patient outcomes in NSCLC.
Main Results:
- Pharmacogenomics shows promise for enhancing survival in select NSCLC subpopulations.
- Genetic factors are increasingly recognized as key determinants of treatment efficacy.
- Personalized medicine approaches are becoming vital in NSCLC management.
Conclusions:
- A pharmacogenomic strategy offers a potential pathway to significantly improve survival rates in specific non-small cell lung cancer patient cohorts.
- Understanding individual genetic profiles can profoundly influence clinical decision-making for NSCLC treatment.
- The integration of pharmacogenomics is poised to reshape the future of NSCLC therapeutic strategies.
More Related Videos
Related Concept Videos
01:20Measurement of Bioavailability: Pharmacodynamic Methods
236
Pharmacodynamic methods provide insights into a drug's effects on physiological processes over time and play a crucial role in understanding bioavailability and therapeutic efficacy. These methods can be broadly classified into acute pharmacological and therapeutic response approaches, each with distinct mechanisms and applications.The acute pharmacological response method directly correlates a drug's physiological effects, such as ECG or pupil diameter changes, to its time course in the body.
236
01:01Dosage Regimens: Partial Pharmacokinetic Parameters
155
It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...
155
01:20Pharmacokinetic Models: Overview
1.9K
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
1.9K
01:21Pharmacodynamics: Overview and Principles
2.8K
Pharmacodynamics is a scientific field that delves into drugs' intricate biochemical, cellular, and physiological effects on the human body. The study of pharmacodynamics helps us understand how drugs interact with the body and elicit various responses.
Most drugs' effects result from their interactions with drug receptors or targets within the body. These interactions trigger specific responses at the cellular or systemic level. Drug receptors can be found on the surfaces of cells or...
Most drugs' effects result from their interactions with drug receptors or targets within the body. These interactions trigger specific responses at the cellular or systemic level. Drug receptors can be found on the surfaces of cells or...
2.8K
02:02Genomics
39.7K
Genomics is the science of genomes: it is the study of all the genetic material of an organism. In humans, the genome consists of information carried in 23 pairs of chromosomes in the nucleus, as well as mitochondrial DNA. In genomics, both coding and non-coding DNA is sequenced and analyzed. Genomics allows a better understanding of all living things, their evolution, and their diversity. It has a myriad of uses: for example, to build phylogenetic trees, to improve productivity and...
39.7K
01:12Analysis of Population Pharmacokinetic Data
682
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
682